14 March, 2024Mission Therapeutics raises £25.2 million to progress clinical candidates in the area of mitophagy
23 January, 2024Enthera Pharmaceuticals appoints Lisa M. Olson as CEO and announces clinical trial progress with Ent001
8 January, 2024NanoPhoria appoints Dr. Suman Shirodkar as chair and Prof. Michael Davidson as non-executive member of the Board of Directors
15 November, 2023T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment